Don’t want emails from us anymore? Click here to unsubscribe.

A satellite-powered analytics firm is soaring after resolving a key business dispute, a building materials maker is tanking after missing its earnings estimates, and a household-name maintenance brand posted a strong earnings beat. Read on to find out more.

Energy (Sponsored)

On Behalf of Azincourt Energy Corp

The US Uranium Crisis = A BIG Opportunity

The US barely produces any uranium—even as it pushes for energy dominance.

90 percent of America’s uranium is imported

The US produced just 121,296 pounds of uranium in Q3 2024

The Trump administration is scrambling to rebuild domestic supply

That’s why Canada’s uranium companies are perfectly positioned to fill the gap.

One uranium junior, sitting on high-grade assets in Canada’s Athabasca Basin and Central Mineral Belt, could become a key player in North America’s nuclear resurgence.

Momentum is building. And the market hasn’t caught on yet.

Learn why this uranium stock is turning heads.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities

Futures 📈

What to Watch

Earnings:

Economic Reports:

Next Big Tesla Play (Sponsored)

Bigger than Tesla’s IPO?

When Tesla rolled out its first cars, it helped send stocks soaring as high as 900%... 1,766%... and 2,000% over time.

When Uber reinvented ridesharing, it helped deliver long-term gains up to 1,401%... 2,798%... and more.

And now, as early as June 1, Tesla is set to reinvent the automotive world again.

(When you click the link, your name will automatically be added to Jeff’s guest list.)

Only this time, Elon Musk believes it could create “the biggest asset value appreciation in history.”

Silicon Valley insider Jeff Brown will share the details during The Robotaxi Emergency Briefing on Thursday, April 10, at 1 p.m. ET

Click here to register with a single click.

(When you click the link, your name will automatically be added to Jeff’s guest list.)

Building Materials

RPM Sees Q3 Earnings Slip Amid Construction Slowdown

RPM International (NYSE: RPM) reported a drop in third-quarter earnings, citing adverse weather that disrupted construction activity across key U.S. markets.

For the three months ending February 28, the building materials manufacturer posted net income of $52 million, or $0.40 per share, down from $61.2 million, or $0.47 per share, in the same period last year.

Adjusted earnings came in at $0.35 per share, falling short of analysts’ expectations of $0.50, according to FactSet.

Revenue declined 3% to $1.48 billion, also missing the $1.51 billion consensus estimate.

RPM stock is down 6.3% in premarket trade.

CEO Frank Sullivan says that weather disruptions began in early January and intensified throughout the quarter.

Cold conditions in southern states, typically active during the winter construction season, and wildfires in western regions significantly reduced demand for RPM’s products.

Looking ahead, the company expects fourth-quarter sales to remain flat. Growth in the performance coatings segment is anticipated to be offset by weakness in the specialty-products and consumer businesses.

Shares of RPM International are down 6.9% in premarket trading as investors react to the earnings miss and muted forecast.

Multi-Use Products

WD-40 Reports Strong Q2, Raises Full-Year Margin and EPS Forecasts

WD-40 Company’s (NASDAQ: WDFC) second-quarter results showed strong momentum in its core maintenance business, with earnings climbing sharply and full-year guidance moving higher.

For the quarter ending February 28, the company reported net sales of $146.1 million, up 5% year-over-year.

Maintenance product sales rose 6% to $139.3 million, helping offset foreign currency headwinds that shaved $4.9 million from total revenue.

The Americas and EIMEA regions were key drivers of sales volume growth, while Asia-Pacific showed early signs of recovery in March.

Gross margin improved to 54.6%, up from 52.4% last year, and operating income rose 11% to $23.3 million.

Net income jumped 92% to $29.9 million, largely due to an $11.9 million tax benefit.

Excluding that one-time item, adjusted net income increased 15% year-over-year. Adjusted earnings per share came in at $1.32, up 16% from the prior-year period.

CEO Steve Brass says that the company continues to see double-digit volume growth and margin expansion.

Management has raised its full-year 2025 guidance for both gross margin and adjusted EPS, reflecting confidence in continued growth across global markets.

Breakout Trade Watch (Sponsored)

Tired of Missing Big Moves? Here’s What Traders Are Watching

Some of the market’s fastest-moving stocks never make the front page—until it’s too late.

That’s why seasoned traders rely on curated alerts to spot momentum plays early, before the buzz and the crowd.

These alerts aren’t about hype. They’re about timing, patterns, and setups that hint at something bigger brewing.

(By clicking any of the links above, you agree to receive emails from GuyStocks. You can opt out at any time. - Privacy Policy)

If you're ready to stop guessing and start getting ahead…

[Sign up here to receive your next stock alert—for free.]

(By clicking any of the links above, you agree to receive emails from GuyStocks. You can opt out at any time. - Privacy Policy)

Cannabis

Tilray Cannabis Revenue Falls 14% in Q3, But Margins and Global Strategy Strengthen

Tilray Brands (NASDAQ: TLRY) reported a 14% drop in net revenue to $186 million, or $193 million on a constant currency basis, in its Q3 results.

The decline is primarily driven by product streamlining and strategic shifts, which impacted revenue by approximately $13 million.

Tilray Brands’ stock is down 3.33% in premarket trade.

Despite the drop in top-line figures, the company achieved its highest cannabis gross margin in nearly two years, improving by 800 basis points.

Tilray maintained its market-leading position in Canada and saw strong growth in Germany’s medical cannabis sector.

In the U.S., Tilray expanded its distribution of hemp-derived THC beverages to 10 states, while increasing its Project 420 cost savings initiative to $33 million.

The company reported no immediate impact from the latest international tariffs, citing domestic production and localized distribution in the U.S. and Canada.

Its wellness subsidiary, Manitoba Harvest, also remains unaffected due to tariff exemptions.

Tilray further improved its financial standing by reducing $58 million in convertible notes and lowering total debt by $71 million.

The company now holds $248 million in cash and marketable securities.

CEO Irwin Simon emphasized the firm’s focus on long-term sustainability, stating that Tilray will continue to prioritize margin improvement, disciplined capital allocation, and product innovation across its beverage, cannabis, and wellness verticals.

Spire Global, Inc. [SPIR] - Last Close: $7.48

Spire Global is a space-based data and analytics company.

Its shares are soaring 33% in premarket trading after the company announced it reached a resolution with Kpler regarding their disputed $241 million maritime business sale.

The agreement puts an end to the ongoing litigation and sets a deadline for closing the deal by April 25, which clears a major overhang on the stock.

ECARX Holdings Inc. [ECX] - Last Close: $1.00

​ECARX Holdings is a global mobility tech company.

Its shares are gaining in premarket trading after the company announced an upsized and extended share repurchase program, increasing the buyback authorization from $20 million to $40 million and extending it through March 31, 2026.

Pacira BioSciences, Inc. [PCRX] - Last Close: $22.91

Pacira BioSciences is a leader in non-opioid pain management therapies. It is best known for Exparel, a long-acting local anesthetic used to reduce post-surgical pain.

Its stock is up in premarket trading after Pacira announced a favorable patent litigation settlement concerning Exparel.

The agreement with Fresenius Kabi and eVenus Pharmaceuticals delays the entry of generic competition until early 2030, well ahead of the 2044 patent expiration, giving Pacira years of continued market exclusivity.

Clean Energy Metals (Sponsored)

On Behalf of Azincourt Energy Corp

The Next Big Name in Uranium?

Billionaires are backing uranium. Governments are pouring in billions.

The uranium bull market is just getting started.

And one tiny uranium junior is sitting on the kind of high-potential assets that turned UEC into a $3.11 billion powerhouse.

Prime uranium assets in the Athabasca Basin and the Central Mineral Belt

Advancing exploration with new data analysis

Institutional investors quietly moving into uranium

With the Trump administration fast-tracking policies to boost domestic uranium production, this company is in a perfect position to capitalize.

The market hasn’t caught on yet, but it won’t stay this way for long.

Find out the symbol before the crowd catches up.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club